Limiting habenular hyperactivity ameliorates maternal separation-driven depressive-like symptoms. by Tchenio, A. et al.
ARTICLE
Limiting habenular hyperactivity ameliorates
maternal separation-driven depressive-like
symptoms
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Early-life stress, including maternal separation (MS), increases the vulnerability to develop
mood disorders later in life, but the underlying mechanisms remain elusive. We report that
MS promotes depressive-like symptoms in mice at a mature stage of life. Along with this
behavioral phenotype, MS drives reduction of GABAB-GIRK signaling and the subsequent
lateral habenula (LHb) hyperexcitability—an anatomical substrate devoted to aversive
encoding. Attenuating LHb hyperactivity using chemogenetic tools and deep-brain stimula-
tion ameliorates MS depressive-like symptoms. This provides insights on mechanisms and
strategies to alleviate stress-dependent affective behaviors.
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Childhood neglect (i.e., maternal separation, MS) is aver-sive, has negative long-term repercussions on childdevelopment and primes depression in adulthood1, 2. The
prolonged separation of newborn rodents from their mother
represents an animal model of severe early-life stress that reca-
pitulates aspects of child neglect. Animals undergoing MS present
deﬁcits in coping with stressful events. Moreover, such paradigm
promotes anxiety, addictive and depressive-like behavioral phe-
notypes3–5. This raises the hypothesis that MS-driven behavioral
adaptations may, at least partly, emerge from the dysfunction of
neural circuits devoted to aversion processing.
The lateral habenula (LHb) contributes to encode aversion and
negative reward prediction error as neurons in this structure are
excited by external aversive stimuli6,7. The LHb provides such
aversive-related information to monoaminergic centers suggest-
ing a relevant role in motivated behaviors8–10. Stressors of dif-
ferent nature increase the activity of LHb neurons, and lesioning
experiments indicate that the LHb regulates coping behaviors
when facing aversive stimuli11–13. Furthermore, when such
stressful events (i.e., foot-shocks) become inescapable and per-
sistent, this produces aberrant LHb hyperactivity, which is
instrumental for the emergence of depressive-like
symptoms11, 12, 14, 15.
However, whether chronic, painless stressful events, such as
MS, promote depressive-like phenotypes through LHb adapta-
tions remains elusive. If this holds true, we propose that reversal
strategies restoring LHb function can ameliorate MS-dependent
depressive-like symptoms.
Here, we demonstrate that, at a mature stage of life, mice
undergoing MS present depressive-like behaviors along with
increased LHb neuronal excitability. In addition, we show that
MS-mediated reduction in GABAB-GIRKs signaling is causal for
such LHb hyperexcitability, and that limiting LHb neuronal
activity through chemogenetics or deep brain stimulation ame-
liorates MS-driven behavioral phenotypes. These ﬁndings support
the notion that aberrant habenular neuronal hyperactivity
represents a neurobiological substrate underlying discrete stress-
driven (i.e., acute and chronic) depressive-like symptoms.
Results
MS drives depressive-like states and habenular hyperexcit-
ability. We examined the early-life stress-dependent behavioral
ramiﬁcations exposing mice to maternal separation (MS)16
(Methods, Fig. 1a). Brieﬂy, pups aged 7 days were, or not
(Control), removed from their litter, separated from their mother,
and kept in isolation for 6 h daily for a week. When tested three
weeks later, Control and MS mice had comparable weight,
locomotion and performance in the open ﬁeld (Supplementary
Fig. 1a–c). In contrast, MS mice presented higher failure rates
when challenged with escapable foot-shocks (shuttle box), beha-
vioral despair (higher immobility in tail suspension test; TST), and
diminished sucrose preference (Fig. 1b–d). Furthermore, ex-vivo
recordings in acute LHb-containing brain slices revealed that LHb
neurons from MS mice exhibit hyperexcitability, with no altera-
tions of the resting membrane potential (Fig. 1e; Supplementary
Fig. 1d). Altogether, these ﬁndings suggest that MS promotes
depressive-like symptoms and LHb hyperactivity later in life.
Cellular mechanisms underlying MS-driven plasticity. Tonic
GABAB-GIRK signaling controls LHb neuronal ﬁring and its
reduction promotes cell hyperexcitability11. Patch-clamp record-
ings from LHb neurons revealed that bath application of the
GABAB-R agonist baclofen evoke an outward current
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Fig. 1 MS-induced depressive-like symptoms and hyperexcitability. a MS protocol (all schematics are original drawing made by authors). b Bar graph and
scatter plot of failures in the shuttle box for control (Ctrl) and MS mice (Ctrl vs. MS; nmice= 24, unpaired t-test, t45= 3.36 **p< 0.01). c Same as b for TST
immobility (Ctrl vs. MS; nmice= 6–7; unpaired t-test, t11= 4.63; ***p< 0.001). d Same as b but for sucrose preference (Ctrl vs. MS; nmice= 16; unpaired t-
test, t30= 32.12; *p< 0.05). e Top, sample traces from Ctrl and MS mice of current-evoked ﬁring (50 pA step). Bottom, action potentials vs. injected
current (0–100 pA, steps of 10 pA) in all experimental groups (Ctrl vs. MS; aCSF, nmice= 6 per group; ncells= 23 per group; two-way ANOVA-RM,
interaction, F(10;440)= 2.74; **p< 0.01). Scale bars=0.2 s and 20mV
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(I-Baclofen) readily reversed by the speciﬁc antagonist CGP-
54626 (Fig. 2a). I-Baclofen was signiﬁcantly reduced throughout
the LHb of MS mice (Fig. 2b, Supplementary Fig. 2a, b). The
reduction of I-Baclofen, with no evident territorial speciﬁcity,
suggests that MS reduces GABAB-GIRKs independently of the
structures to which LHb neurons send their axons. To test this
prediction, we used ﬂuorescent tract tracing to retrogradely label
LHb neurons projecting either to the ventral tegmental area
(LHbVTA) or the rostromedial tegmental nucleus (LHbRMTg).
These are prominent habenular-midbrain projections that, if
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Fig. 2 MS drives GABAB-GIRK plasticity in LHb. a Sample traces, bar graph and scatter plots depicting CGP54626-sensitive I-Baclofen (I-Baclofen Ctrl vs.
MS; nmice= 5/6; ncells= 13; unpaired t-test, t24= 2.67 *p< 0.05). I-Baclofen was measured at steady state. b Territorial distribution of I-Baclofen showing
MS-dependent reduction of GABAB-GIRK signaling throughout the LHb. c Examples of the injection site of red retrobeads infused in the VTA (top) and in
the RMTg (bottom). Right, retrogradely labeled LHb neurons projecting to VTA or RMTg. d Sample traces, bar graph and scatter plots depicting
CGP54626-sensitive I-Baclofen in LHbVTA and LHbRMTg neurons (LHBVTA: I-Baclofen Ctrl vs. MS; nmice= 2; ncells= 9; unpaired t-test, t16= 2.37 *p< 0.05;
LHbRMTg: I-Baclofen Ctrl vs. MS; nmice= 2; ncells= 9 vs. 7; unpaired t-test, t14= 2.35 *p< 0.05). e Stereotactic infusion of AAV2-hSyn-CoChR-GFP within
the EPN, and opsin expression in terminals within the LHb f Opto-GABAA-IPSCs and opto-GABAB-IPSC sample traces and summary plot (Ctrl vs. MS;
nmice= 6/3; ncells= 9 per group; unpaired t-test, t16= 2.21; *p< 0.05). Values for opto-GABAA-IPSC and opto-GABAB-IPSC were taken at the maximal peak
as indicated. Scale bars=4min and 50 pA a, 500 and 125 μm c, 5 min and 20 pA d, 0.5 mm and 200 μm e, 0.5 s and 10 pA
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disrupted, contribute to the establishment of depressive-like
symptoms8, 12. MS signiﬁcantly reduced I-Baclofen in both
LHbVTA and LHbRMTg neurons supporting a scenario in which
GABAB-GIRK signaling reduction occurs throughout the LHb,
likely affecting multiple downstream targets (Fig. 2c, d).
GABAB-R activation within the LHb leads to cell hyperpolar-
ization through GIRK channels opening11. Along with the
reduced I-Baclofen, MS also diminished GIRK currents. Indeed,
responses generated by the intracellular dialysis of the G-protein
activator GTPγS (I–GTPγS) and the bath application of the
speciﬁc GIRK1/2 activator ML-297 were smaller throughout the
LHb of MS mice (Supplementary Fig. 2c, d)17, 18. These results
indicate that early-life stress, similarly to foot-shocks11, 19,
reduces GABAB-GIRK function within the LHb.
Activation of the GABAB-GIRK signaling requires GABA
spillover from the presynaptic terminal20. A major input source
of GABA onto LHb neurons arises from the entopeduncular
nucleus (EPN). Furthermore, the reduction of EPN-originating
inhibitory transmission within the LHb contributes to depressive-
like symptoms15, 21, 22. We therefore set out to provide proof of
principle that MS reduces, not only agonist-evoked GABAB-R
responses, but more precisely synaptically-relevant GABAB-R
function. To probe synaptically-activated GABABRs, we trans-
duced EPN neurons with a rAAV2-hSyn-CoChR-eGFP allowing
for the expression of the excitatory opsin from Chloromonas
oogama (CoChR; Fig. 2e)23. CoChR-expressing EPN terminals
received trains of light-pulses (20 Hz), which elicited fast-
GABAAR and slow-GABAB-R outward currents (I-GABAA and
I-GABAB-slow respectively), the latter likely mediated by GABA
spillover diffusing to perisynaptic GABAB-Rs (Fig. 2f). We then
computed the I-GABAB-slow/I-GABAA ratios as a measure of the
postsynaptic strength of inhibitory transmission. MS diminished
the I-GABAB-slow/I-GABAA ratios without signiﬁcant alterations
in miniature EPSCs or IPSCs, nor on presynaptic GABAB-R
function (Fig. 2f, Supplementary Fig. 3a–d). Altogether, MS
diminishes postsynaptic GABAB-GIRK signaling in LHb.
Thus, we predicted that MS-dependent LHb hyperexcitability
results from the above-described GABAB-GIRK reduction.
Blocking GABAARs, AMPARs and NMDARs left MS hyperexcit-
ability unaffected. However, MS occluded GABABRs antagonism-
driven increased neuronal excitability observed in control slices
(Fig. 1e, Fig. 3a, b; (Ctrl, aCSF/CGP54626, F(10;410) = 2.3 p< 0.05;
MS, aCSF/CGP54626, F(10;410)= 0.37 p> 0.05; two-way ANOVA
RM, interaction). This suggests that MS leads to LHb hyperexcit-
ability via GABAB-GIRK plasticity.
Limiting habenular activity ameliorates depressive-like symp-
toms. Is LHb hyperexcitability necessary for MS depressive-like
phenotypes? MS-driven adaptations occur throughout the LHb
(Fig. 2b–d). Therefore, we sought to limit hyperactivity of a
large LHb neuronal population. Thus, we virally expressed the
inhibitory designer receptors exclusively-activated by designer
drugs (rAAV8-hSyn-HA-hM4Di-mCherry; Gi-DREADD) in the
LHb (Fig. 4a, Supplementary Fig. 4a). Ex-vivo, bath application of
the speciﬁc DREADDi ligand clozapine-N-oxide (CNO) gener-
ated a K+-dependent outward current (I-CNO) and abolished
neuronal ﬁring (Supplementary Fig. 4b, c). MS reduced I-CNO,
supporting a diminished GIRK function24. We next examined
baseline neuronal activity using single unit recordings in anes-
thetized mice. The baseline ﬁring rate of MS mice was higher than
Control animals, an observation in line with the increased
excitability reported in acute slices. The systemic injection of
CNO diminished LHb neuronal ﬁring in Gi-DREADD-
expressing mice, and reduced the activity of MS-LHb neurons
to values not statistically different from Control animals (Sup-
plementary Fig. 4d, e). This validates this strategy to limit
hyperexcitability in behaving mice. When exposed to escapable
foot-shocks (shuttle box), in the absence of CNO MS mice
(YFP/Gi-DREADD) expressed high failure rates (Fig. 4b). After a
recovery period of 3 days, mice of all experimental groups
received a single systemic injection of CNO ~15min prior the
test. CNO reduced the failure rate in the shuttle box only in Gi-
DREADD-expressing MS mice. However, 5 days later, after
complete clearance of CNO from the animal body, MS mice
displayed the depressive state (Fig. 4b). Accordingly, in different
sets of mice treated with CNO (see Methods), TST immobility
and sucrose preference were comparable between Gi-DREADD-
expressing MS mice and Controls (Fig. 4c, Supplementary
Fig. 4f). In contrast, CNO treatment did not affect locomotor
activity measured in the open ﬁeld, arguing against compromised
motor function (Supplementary Fig. 4f). Therefore, the chemo-
genetic reduction of LHb activity is sufﬁcient to ameliorate
MS-driven depressive-like symptoms.
Individuals presenting symptoms of depression following
early-life stress poorly respond to antidepressants25, heightening
the need of alternative treatments. Deep brain stimulation (DBS)
of the LHb ameliorates depressive symptoms, but its efﬁciency in
the context of MS is unknown12, 26. When applied ex-vivo within
the LHb, DBS-like stimulation (130 Hz)12 reduced glutamate
release, diminished neuronal ﬁring, hyperpolarized neurons and
decreased input resistance (Fig. 4d, e). Accordingly, in
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anesthetized mice, DBS lowered LHb activity (Fig. 2f, g and
Supplementary Fig. 4g). Therefore, DBS reduces neuronal activity
by engaging both presynaptic and postsynaptic mechanisms. We
then unilaterally implanted DBS electrodes in LHb (Fig. 4f), and
examined its efﬁcacy on MS-induced depressive-like behavior.
DBS reduced the number of failures in the shuttle box (Fig. 4h).
This highlights DBS as a strategy, complementary to pharmacol-
ogy, to compensate for MS-driven LHb hyperexcitability and
ameliorate depressive states.
Discussion
Here we demonstrate that MS promotes LHb neuronal hyper-
activity by reducing GABAB-GIRK function. This hyperexcit-
ability ultimately triggers depressive-like symptoms.
The GABAB-GIRK signaling in the LHb tightly controls neu-
ronal activity11 and GABAB-R internalization often occurs along
with GIRK trafﬁcking11, 27, 28. Consistently, we report that MS-
driven reduced GABAB-Rs function occurs along with diminished
GIRK channels either expression or function. Internalization of
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GABAB-Rs and GIRKs requires the activity of phosphatases
including PP2A, and a PP2A inhibitor presents antidepressant
properties11, 27, 28. However, whether PP2A contributes to MS-
driven GABAB-GIRK plasticity in the LHb remains to be
established.
In line with a reduction of I-Baclofen, we observed a dimin-
ished I-GABAB-slow/I-GABAA ratios at EPN-to-LHb synapses.
These ﬁndings provide new insights on (i) Physiological patterns
of presynaptic activity to elicit synaptic GABAB-Rs in the LHb;
(ii) MS-mediated plasticity of synaptically-evoked GABAB-Rs.
However MS-driven GABAB-Rs reduction may also occur at
synaptic inputs other than the EPN.
Our data indicate that MS does not signiﬁcantly affect mIPSCs,
however these events stem from unidentiﬁed inputs, leaving open
the possibility that MS also engages input-speciﬁc changes of fast
inhibitory transmission15, 21. In addition, the learned helplessness
depressive state potentiated fast excitatory transmission onto
LHbVTA neurons12. We cannot completely rule out that a similar
adaptation also occur in MS mice. The detection threshold for MS
plasticity of mEPSCs might be lowered by the different animal
model of depression employed or, alternatively, by circuit-speciﬁc
adaptations yet to be identiﬁed. Overall, plasticity of GABAB-GIRKs
in the LHb emerges as a general cellular substrate underlying
stressor-driven depressive phenotypes as it is common to acute
traumatic events and chronic stressful conditions such as MS11, 19.
Reduced GABAB-GIRK signaling mediates LHb neuronal
hyperactivity11. Considering that MS-driven plasticity occurs in
VTA and RMTg-projecting LHb neurons, MS cellular adapta-
tions may remodel target midbrain circuits highlighting LHb-to-
midbrain relevance in mood disorders3, 8, 12. The habenular
output connectivity is however complex indicating that LHb-
receiving structures other than the midbrain may contribute to
the MS-driven behavioral phenotypes. This is indeed likely, as the
inactivation of the LHb fails to rescue aberrant dopamine neurons
activity in the chronic mild stress model of depression29. Alto-
gether, stress-driven depressive-like symptoms emerge from the
dysfunction of complex and parallel neuronal circuits (i.e., LHb-
related and midbrain-related)11, 29–31.
MS-dependent hyperactivity can be limited by chemogenetic
and DBS approaches, which in turn are efﬁcient to ameliorate
MS-mediated depressive-like phenotypes.
Our data provide an extensive description of Gi-DREADD
efﬁciency at the single-cell level ex-vivo and in-vivo within the
LHb. We report that Gi-DREADD activation in vivo in the LHb
reduces, but does not silence, neuronal activity. This highlights
Gi-DREADD efﬁcacy in rescuing aberrant activity, without
abruptly altering the physiology of neural systems. These prop-
erties may differ according to neuronal populations, viral vector
properties or promoter employed.
In addition to a chemogenetic-based strategy we also investi-
gated the use of DBS approaches to reduce MS hyperactivity in
the LHb. The high-frequency DBS protocol reported in our work
was previously shown to also ameliorate depressive symptoms
emerging in congenital learned helplessness rats12. Our data
suggest that DBS efﬁciency not only relies on reduced presynaptic
release12, but also on postsynaptic mechanisms. The DBS-
mediated modulation of LHb activity is however transient, sug-
gesting that the MS depressive-like phenotypes can re-emerge
after the intervention12. This indicates that DBS efﬁcacy stems
from its pre/postsynaptic-mediated reduction in LHb neuronal
activity rather than on the MS-driven plasticity expression
mechanisms (i.e., GABAB-GIRK plasticity).
Altogether, this study provides mechanistic insights underlying
MS-induced adaptations in the LHb. Moreover, limiting LHb
neuronal activity has potential therapeutic relevance in alleviating
affective symptoms of neuropsychiatric disorders.
Methods
Experimental subjects and MS paradigm. All procedures were used in accor-
dance with the guidelines of the French Agriculture and Forestry Ministry for
handling animals (Committee Charles Darwin #5, University Pierre et Marie Curie,
Pairs). Part of the current study was carried out in the Department of Fundamental
Neuroscience (Lausanne, Switzerland) under license and according to regulations
of the Cantonal Veterinary Ofﬁces of Vaud and Zurich (Switzerland). Pregnant
dams C57Bl/6J were received at the gestational stage E13–18 (Janvier Laboratories,
France). Mothers were housed 2 per cages with access of food and water ad libitum.
After birth, pups of either sex remained untouched until postnatal day (P) 7. At P7,
litters were randomly divided in 2 groups. The maternal separation group consisted
of pups removed from their litter and isolated in small compartments for 6 h
per day (light phase 0800:1900 hours) repeated from P7 to P15 and followed by an
early weaning at P17. During the separation, animals were maintained in heating
plate and water was provided, maintaining constant temperature and humidity.
The control group consisted of mice from independent litters, which were not
manipulated until the regular weaning at P21 except during cage changing. During
cage changing some old bedding and nest were transferred into the new cage in
order to limit novelty stress. After weaning, mice where separated by sex and
housed 6 per cage. Experiments were performed in mice aged 4–8 weeks.
Surgery. Animals, aged at least 24 days were anesthetized with Ketamine (150 mg
kg−1)/Xylazine (100 mg kg−1 i.p.) before bilateral injection of rAAV8-Hsyn-Gi-
DREADD-mCherry (University of Pennsylvania, US) in the LHb at the following
coordinates (from bregma, in mm): A-P: –1.45; M-L:±0.45; D-V: –3.1. After three
weeks, mice were subjected to CNO i.p injection (1 mg kg−1) for the DREADD
activation. For optogenetic experiments rAAV2.1-hSyn-CoChr-eGFP (University
of North Carolina, US) was infused in the entopeduncular nucleus (from bregma,
in mm: A-P: –1.25; M-L:±1.8; D-V: –4.65). Recordings were performed 3 weeks
after surgery. The injection sites were carefully examined and only animals with
correct injections were kept for behavioral and electrophysiological analysis. DBS
electrodes were unilaterally implanted using similar procedures and coordinates in
the LHb. DBS electrodes were chronically implanted using a Superbond resin
cements (Sun medical, Japan). For the experiment analyzing the output speciﬁcity
of I-Baclofen, mice were bilaterally injected with a mixture of herpes simplex virus
(McGovern Institute, USA) expressing enhanced GFP and red retrobeads
(Lumaﬂuor, US) into the RMTg or the VTA. The following coordinates were used
(RMTg: from bregma, in mm: A-P: –2.9; M-L:±0.5; D-V: –4.3; VTA: from bregma,
in mm: A-P: –2.4; M-L:±0.65; D-V: –4.9). Recordings from ﬂuorescent LHb
neurons were performed± 12 days following the surgery, and injection site were
veriﬁed using the retrobeads labeling.
Behavioral paradigm. All experimental behaviors were performed during the light
phase and experimenters were blind of their experimental group.
The shuttle box test was performed in a shuttle box (13 × 18 × 30 cm3) equipped
with an electriﬁed grid ﬂoor and a door separating the two compartments. The test
session consisted of 30 trials of escapable foot-shocks (10 s at 0.1–0.3 mA)
separated by an interval of 30 s. The shock terminated any time that the animal
shuttled in the other compartment. Failure is deﬁned as the absence of shuttling to
the other compartment within the 10 s shock delivery.
The tail suspension test was performed with mice being suspended by their tails
with adhesive tape for a single session of 6 min. Immobility time of each animal
was scored online by the experimenter. Mice were considered immobile only when
they suspended passively and motionless.
The sucrose test preference was performed with mice being single-housed and
habituated with two bottles of 1% sucrose for 2 days. At day 3 (test day) mice were
exposed to two bottles ﬁlled with either 1% sucrose or water for 24 h. The sucrose
preference was deﬁned as the ratio of the consumption of sucrose solution vs. total
intake (sucrose+water) during the test day and expressed as a percent.
Behavioral experiments in DREADD-injected animals were performed three
weeks after viral infusion. For the shuttle Box, the tail suspension test, and the
locomotor activity all the groups (YFP or DREADDi injected animals) were
injected 15 min with CNO i.p. (1 mg kg−1). For sucrose preference experiments, all
groups were injected with CNO i.p. (1 mg kg−1) every 3 h for the extent of the
preference session (24 h) to maintain a constant DREADD-mediated inhibition.
Electrophysiology. For in vitro recordings, animals were anesthetized with keta-
mine and xylazine (i.p. 150 mg kg−1 and 100 mg kg−1, respectively). Coronal brain
slices (250 µm) containing the LHb were prepared in bubble ice-cold 95% O2/5%
CO2-equilibrated solution containing: 110 mM choline chloride; 25 mM glucose;
25 mM NaHCO3; 7 mM MgCl2; 11.6 mM ascorbic acid; 3.1 mM sodium pyruvate;
2,5 mM KCl; 1.25 mM NaH2PO4; 0.5 mM CaCl2. Slices were then stored at room
temperature in 95% O2/5% CO2-equilibrated artiﬁcial cerebrospinal ﬂuid (ACSF)
containing: 124 mM NaCl; 26.2 mM NaHCO3; 11 mM glucose; 2.5 mM KCl; 2.5
mM CaCl2; 1.3 mM MgCl2; 1 mM NaH2PO4. Recordings (ﬂow rate of 2.5 ml min
−1) were made under an Olympus-BX51 microscope (Olympus, France) at
30 °C. Currents were ampliﬁed, ﬁltered at 5 kHz and digitized at 20 kHz. Access
resistance and input resistance were monitored by a step of −4 mV (0.1 Hz).
Experiments were discarded if the access resistance increased >20%.
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The internal solution used to examine GABAB and/or GIRK currents and
neuronal excitability contained: 140 mM potassium gluconate, 4 mM NaCl, 2 mM
MgCl2, 1.1 mM EGTA, 5 mM HEPES, 2 mM Na2ATP, 5 mM sodium creatine
phosphate, and 0.6 mM Na3GTP (pH 7.3 with KOH). The liquid junction potential
was ~12 mV. When we measured the synaptic inhibitory or excitatory release, the
internal solution contained: 130 mM CsCl; 4 mM NaCl; 2 mM MgCl2; 1.1 mM
EGTA; 5 mM HEPES; 2 mM Na2ATP; 5 mM sodium creatine phosphate; 0.6 mM
Na3GTP; and 0.1 mM spermine. The liquid junction potential was −3 mV. Whole-
cell voltage-clamp recordings were achieved to measure GABAB-GIRK currents in
aCSF only. For agonist-induced currents, changes in holding currents in response
to bath application of baclofen (100 µM) were measured (at −50 mV every 5–10 s).
The plotted values correspond to the difference between the baseline and the
plateau (for the baclofen and ML297 experiments) or the difference between the
plateau and the value of holding current after barium (for the I-GTP-γS) GABAB-
GIRK currents were conﬁrmed by antagonism with 10 μM of CGP54626. When
stated, 100 μM of GTP-γS was added to the internal solution in place of Na3GTP.
Plateau currents were then reversed by 1 mM Barium application, a selective
inhibitor of K+channels. Changes in holding currents in response to GIRK agonist
were measured (at −50 mV every 5–10 s) by bath application of ML-297 (50 µM), a
Selective GIRK1/2 channel activator then reversed by 1 mM Barium application.
Synaptic GABAB slow IPSCs were optically evoked by trains of 10 pulses delivered
at 20 Hz through a 470 nm LED. The fast GABA amplitude correspond to the
amplitude of the ﬁrst pic of the train, the slow GABA current instead were
measured after picrotoxin bath application, and correspond to the
I-max. Miniature excitatory postsynaptic currents (mEPSCs) were recorded in
voltage-clamp mode at −60 mV in the presence of bicuculline (10 μM), AP5
(50 μM) and tetrodotoxin (TTX, 1 μM). Miniature inhibitory postsynaptic currents
(mIPSCs) were recorded (−60 mV) in the presence of NBQX (20 μM) AP5 (50 μM)
and TTX (1 μM). EPSCs were evoked through an ACSF-ﬁlled monopolar glass
electrode placed in the LHb. For the experiments in which high-frequency
stimulation trains were used to determine presynaptic release probability (5 pulses
at 20 Hz), QX314 (5 mM) was included in the internal solution to prevent the
generation of sodium spikes.
Current-clamp experiments were performed using a series of current steps
(from −80 to 100 pA or when the cell reached a depolarization block) injected to
induce action potentials (10-pA injection current per step, duration of 500 ms).
Cells were maintained at −55 mV throughout the experiment. When testing
changes in tonic ﬁring, cells were depolarized to obtain stable ﬁring activity in
current-clamp mode.
When in vivo single unit recordings were performed, mice were anesthetized
with isoﬂurane (induction: 2%; maintenance: 1–1.5%) using an anesthesia device
for small animals (Univentor 410, Malta). We placed the mice in the stereotaxic
apparatus (Kopf, Germany) and their body temperature was maintained at
36± 1 °C using a feedback-controlled heating pad (CMA 450 Temperature
Controller, USA). The scalp was retracted and one burr hole was drilled above the
LHb (A-P: –1.3/–1.6; M-L:±0.4/0.5) for the placement of a recording electrode.
Single unit activity of neurons located in the LHb (Ventral 2.3–3.2 mm to cortical
surface) was recorded extracellularly by glass micropipettes ﬁlled with 2%
pontamine sky blue dissolved in 0.5 M sodium acetate (impedance 3–6MΩ). Signal
was pre-ampliﬁed (DAM80, WPI, Germany), ﬁltered (band-pass 500–5000 Hz)
ampliﬁed (Neurolog System, Digitimer, UK), displayed on a digital storage
oscilloscope (OX 530, Metrix, USA), and digitally recorded. Experiments were
sampled on- and off-line by a computer connected to CED Power 1401 laboratory
interface (Cambridge Electronic Design, Cambridge, UK) running the
Spike2 software (Cambridge Electronic Design). Single units were isolated and
identiﬁed according to previously described electrophysiological characteristics
(Meye et al.8) including a broad triphasic extracellular spike (>3 ms), and a tonic
regular, tonic irregular or bursting spontaneous activity.
Isolated LHb neurons were recorded for 5 min to establish the basal
spontaneous ﬁring rate. CNO was administered i.p. (1 mg kg−1) and the ﬁring
activity of the neuron was monitoring every 5 m for total 40 m. When CNO was
administered, only one cell was recorded per mouse.
DBS experiments were performed with a modiﬁed double barrel system
allowing to stimulate in close proximity of the recording site: the stimulating
electrode was attached to the recording one by using glass barrels (the 2 electrodes
form an angle of ±30°). The stimulating tip was glued above the recording tip
(<300 µm). A stable spontaneous ﬁring rate was recorded for 5 min before to start
the DBS protocol (total duration: 2–5 m; Train pulses: 7; ITI: 40 ms; Frequency:
130 Hz; Intensity: 150 µA). The ﬁring activity recorded immediately after the
protocol was compared with the respective baseline.
At the end of each experiment, the electrode placement was marked with an
iontophoretic deposit of pontamine sky blue dye (−80 μA, continuous current for
35 min). Brains were then rapidly removed and ﬁxed in 4% paraformaldehyde
solution. The position of the electrodes was microscopically identiﬁed on serial
sections (60 μm).
Deep brain stimulation. MS mice for DBS experiments were ﬁrst preselected on
the basis of their failure rate in the Shuttle box test (A cutoff of 12 failures was used
for the preselection). In total 50 mice were tested, and 17 of these animals met the
criteria. Standard surgical procedures were used to implant bipolar concentric
electrodes unilaterally into the LHb (coordinates −1.45 mm AP, ±0.45 mm ML and
−3.1 mm DV). After 5 days recovery from surgery, DBS or no (Sham) stimulation
was applied for 1 h (seven stimulus trains of 130 Hz, separated by 40 ms intervals;
150 µA intensity) prior testing each mouse in the shuttle box test.
Analysis and drugs. All drugs were obtained from Abcam (Cambridge, UK) and
Hello Bio, and Tocris (Bristol, UK) and dissolved in water, except for TTX (citric
acid 1%), ML297 and CNO (DMSO). Online/ofﬂine analysis were performed using
IGOR-6 (Wavemetrics, US) and Prism (Graphpad, USA). Data analysis for in vivo
electrophysiology was performed off-line using Spike2 (CED, UK) software.
Sample size required for the experiment was empirically tested by running pilots
experiments in the laboratory. While behavioral experiments were run in a single-
to-triple trial, electrophysiological experiments were replicated at least ﬁve times.
Experiments were replicated in the laboratory at least twice. Animals were ran-
domly assigned to experimental groups. Data distribution was assumed to be
normal, and single data points are always plotted. Compiled data are expressed as
mean± s.e.m. All groups were tested with Grubbs exclusion test (limit set at 0.05)
to determine outliers. Signiﬁcance was set at p < 0.05 using Student’s t-test two-
sided, Kolmogorov–Smirnov test, one-way, two-way or three-way Anova with
multiple comparison when applicable.
Data availability. All relevant data are available from the authors upon request.
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